Impact of Killer-Immunoglobulin-Like Receptor and Human Leukocyte Antigen Genotypes on the Efficacy of Immunotherapy in Acute Myeloid Leukemia

Leukemia - United Kingdom
doi 10.1038/leu.2017.151
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Killer Immunoglobulin-Like Receptor Dilemma: How Do We Harness the Power of Killer Immunoglobulin-Like Receptors?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Recent Developments in Immunotherapy of Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Cell-Selective Oligonucleotide STAT3 Inhibitor for Immunotherapy of Human Acute Myeloid Leukemia

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Clinical Significance of Leukocyte-Associated Immunoglobulin-Like Receptor-1 Expression in Human Cervical Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Natural Killer Cell Immune Escape in Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Acute Myeloid Leukemia Stem Cells and CD33-targeted Immunotherapy

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Human Leukocyte Antigen-G Upregulates Immunoglobulin-Like Transcripts and Corrects Dysfunction of Immune Cells in Immune Thrombocytopenia

Haematologica
Hematology
2020English

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer

Frontiers in Immunology
AllergyImmunology
2018English

New Insights Into Antigen Specific Immunotherapy for Chronic Myeloid Leukemia

Cancer Cell International
Cancer ResearchOncologyGenetics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy